Key facts
- This page summarizes Margery B. Fischbein's Form 4 filing for PALISADE BIO, INC. (PALI).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 Jul 2024, 20:13.
Margery B. Fischbein - 11 Jul 2024 Form 4 Insider Report for PALISADE BIO, INC. (PALI)
- Reporting relationship
- Director
- Issuer ticker
- PALI
- Reported as of
- 11 Jul 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 Jul 2024, 20:13:20 UTC
- Prior SEC filing
- 16 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Margery Fischbein
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Margery B. Fischbein filed Form 4 for PALISADE BIO, INC. (PALI) on 15 Jul 2024.
Change
- Previous filing in this sequence was filed on 16 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PALI
transaction
Derivative
Common Stock Options
Award
- Transaction value
- $0
- Shares
- +2,100
- Change %
- Price
- $0.000000
- Shares after
- 2,100
- Date
- 11 Jul 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,100
- Exercise price
- $4.49
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan.
Footnote F2
The grants vest fully on the one (1) year anniversary of the grant date.
Footnote F3
Each option represents the right to purchase one share of common stock at the exercise price.